Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Patent
1988-07-29
1990-03-20
Lee, Mary C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
558254, A61K 31265, C07C153017, C07C153023
Patent
active
049102222
ABSTRACT:
The present invention covers D or L or DL-cysteine derivatives of the general formula (I) ##STR1## wherein R represents H or a fatty saturated or unsaturated acid radical, or a radical of an aromatic acid such as benzoic, cynnamic, salycilic, 2-acetoxybenzoic acid or a heterocyclic acid, as well as their salts, in particular the Ca and Mg salts.
The invention refers also to a process for preparing said derivatives and to the pharmaceutical preparations containing them as active principle, having a bronchial liquefying and expectorating activity.
REFERENCES:
patent: 2406362 (1946-08-01), Farlow
Lee Mary C.
Magis Farmaceutici SpA
Whittenbaugh Robert C.
LandOfFree
Cysteine derivatives having expectorant activity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cysteine derivatives having expectorant activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cysteine derivatives having expectorant activity will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-793214